Symbols

ECOR

electroCore·NASDAQ

--(--)

ECOR fundamentals

ECOR Q4 2025 Earnings

electroCore (ECOR) released its earnings on Mar 19, 2026: revenue was 9.24M (YoY +31.18%), beat estimates; EPS was -0.34 (YoY +8.11%), beat estimates.

Revenue / YoY

9.24M

+31.18%

EPS / YoY

-0.34

+8.11%

Report date

Mar 19, 2026

ECOR Earnings Call Summary for Q4,2025

Leadership Transition: CEO Dan Goldberger retiring; CFO Joshua Lev becomes interim president, supported by new COO Michael Fox.
Revenue Growth: Q4 2025 revenue $9.2M (31% YoY), full year $32M (27% YoY).
VA Dominance: 200 VA facilities using gammaCore (2% of addressable market); 13,400 patients treated.
DTC Momentum: Truvaga sales $5.4M (93% YoY), ROAS 2.1x.
New Products: Quell Relief launch Q2 2026; next-gen app for recurring revenue.
Financials: Gross margin 87%, net loss $14M (up 19% YoY) due to $7M opex increase.

Earnings

EPS

Revenue

Revenue & Expenses

ECOR has released its 2025 Q4 earnings report, with revenue of 9.24M, reflecting a YoY change of 31.18%, and net profit of -3.04M, showing a YoY change of 5.98%. The Sankey diagram below clearly presents ECOR's revenue sources and cost distribution.

Key Indicators

electroCore (ECOR) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

electroCore (ECOR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

electroCore (ECOR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

electroCore (ECOR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown